Advancements and progress in juvenile idiopathic arthritis: A Review of pathophysiology and treatment

Helen Ye Rim Huang1, Andrew Awuah Wireko2, Goshen David Miteu3,4

  • 1Faculty of Medicine and Health Science, Royal College of Surgeons in Ireland, Dublin, Ireland.

Medicine
|March 29, 2024
PubMed

Insights

Juvenile idiopathic arthritis (JIA) is a complex childhood condition with unknown causes. This review explores genetic factors, diagnostics, and treatments for JIA to improve patient outcomes.

Area of Science:

  • Rheumatology
  • Pediatrics
  • Genetics

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disease affecting children under 16, causing joint inflammation and potential damage.
  • The exact causes of JIA are unknown, but genetic and environmental factors are implicated in its development and progression.
  • JIA presents a heterogeneous clinical phenotype, posing challenges for diagnosis and treatment.

Approach:

  • This review comprehensively analyzes current literature on JIA.
  • It examines diverse research modalities, including in vivo animal models and genome-wide association studies (GWAS).
  • The focus is on understanding pathoaetiologies, diagnostic strategies, and therapeutic interventions for JIA.

Key Points:

  • Genetic predisposition plays a significant role in JIA etiology.
  • Current diagnostic criteria and biomarkers for JIA require further refinement.
  • Advanced research modalities are crucial for elucidating JIA's multifactorial nature.

Conclusions:

  • Improved understanding of JIA's genetic underpinnings can enhance diagnostic risk stratification.
  • Developing novel therapeutic strategies is essential for better management of JIA.
  • Further research is imperative to address the idiopathic nature and heterogeneity of JIA.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
430
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
233